Derek Hicks
Corporate Officer/Principal at INTELLIA THERAPEUTICS, INC.
Net worth: 2 M $ as of 2024-03-30
Profile
Derek Hicks is currently the Chief Business Officer & Executive Vice President at Intellia Therapeutics, Inc. Prior to this, he worked as the Head of Business Development at Spark Therapeutics, Inc. from 2020 to 2021.
Hicks has an undergraduate and graduate degree from the University of Connecticut and an MBA from the Kelley School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-29 | 66,380 ( 0.07% ) | 2 M $ | 2024-03-30 |
Derek Hicks active positions
| Companies | Position | Start |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Corporate Officer/Principal | 2021-12-19 |
Former positions of Derek Hicks
| Companies | Position | End |
|---|---|---|
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 2021-11-30 |
Training of Derek Hicks
| University of Connecticut | Graduate Degree |
| Kelley School of Business | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
- Stock Market
- Insiders
- Derek Hicks
